thiazolidines has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kaya, D; Kitade, M; Kitagawa, K; Mitoro, A; Moriya, K; Nakanishi, K; Namisaki, T; Noguchi, R; Ozutsumi, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Tsuji, Y; Yoshiji, H | 1 |
Alessandrini, G; Buglioni, S; D'Aguanno, S; Del Bufalo, D; Desideri, M; Di Martile, M; Gabellini, C; Pallocca, M; Trisciuoglio, D; Tupone, MG | 1 |
Davis, JJ; Dong, F; Fang, B; Guo, W; Inoue, S; Teraishi, F; Wu, S; Zhang, L | 1 |
3 other study(ies) available for thiazolidines and Angiogenesis, Pathologic
Article | Year |
---|---|
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Topics: Animals; Cadherins; Canagliflozin; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Disease Progression; DNA Damage; Drug Synergism; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Lipid Peroxidation; Liver Cirrhosis; Liver Neoplasms; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Pyrazoles; Rats; Rats, Inbred Strains; Thiazolidines; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |
BCL-X
Topics: Animals; bcl-X Protein; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mice; Mice, Nude; Nanog Homeobox Protein; Neoplastic Stem Cells; Neovascularization, Pathologic; Octamer Transcription Factor-3; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; SOXB1 Transcription Factors; Thiazolidines; Xenograft Model Antitumor Assays | 2017 |
Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 2006 |